Does the age at diagnosis of the proband impact genetic yield, clinical presentation, outcomes, and yield of family screening in hypertrophic cardiomyopathy?
The findings support presently recommended follow-up and family screening irrespective of the proband's age at diagnosis.
The proband's age at hypertrophic cardiomyopathy diagnosis was associated with clinical and genetic findings, but the cardiovascular death and the yield of family screening were similar across all ages at diagnosis, supporting the presently recommended follow-up and family screening irrespective of the proband's age at diagnosis.
Silajdzija et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: